The PPARgamma Agonist Rosiglitazone Impairs Colonic Inflammation in Mice with Experimental Colitis

J.D. Ramakers*, M.I. Verstege, G. Thuijls, A.A. Te Velde, R.P. Mensink, J. Plat

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'The PPARgamma Agonist Rosiglitazone Impairs Colonic Inflammation in Mice with Experimental Colitis'. Together they form a unique fingerprint.

Keyphrases

INIS

Pharmacology, Toxicology and Pharmaceutical Science